Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Regulatory News (ABC)

  • There is currently no data for ABC

Director/PDMR Shareholding

18 Apr 2017 14:24

RNS Number : 6171C
ABCAM Plc
18 April 2017
 

For immediate release

18 April 2017

ABCAM PLC

("Abcam" or "the Company")

Director / PDMR Shareholding

 

 

Cambridge, UK: Abcam plc (AIM: ABC), a global leader in the supply of life science research tools, was notified on 18 April 2017 that on 13 April 2017, the Trustees of the Abcam plc Share Incentive Plan ("Plan") purchased Ordinary Shares of 0.2 pence each in the Company at a price of £8.44 per share under the Plan's provision for dividend re-investment on behalf of the persons listed below:

 

Name of PDMR

Number of Shares

Alan Hirzel

17

Chief Executive Officer

Gavin Wood

3

Chief Financial Officer

Suzanne Smith

7

Chief Legal Officer and Company Secretary

 

No consideration was paid by the above grantees in respect of the Dividend Re-Investment. The shares purchased will be subject to a minimum three year holding period.

For further information please contact:

 

Abcam

+ 44 (0) 1223 696 000

Suzanne Smith, Company Secretary

 

J.P.Morgan Cazenove - Nominated Advisor & Corporate Broker

+ 44 (0) 20 7742 4000

James Mitford / Christopher Cargill

FTI Consulting

+ 44 (0) 20 3727 1000

 

 

 

  

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mr Alan Hirzel

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Abcam plc

b)

Legal Entity Identifier

N/A

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.2 pence each

 

 

 

GB00B6774699

b)

Nature of the transaction

Dividend Re-Investment

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

£8.44

17

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

17

£8.44

£143.48

f)

Date of the transaction

13 April 2017

g)

Place of the transaction

London Stock Exchange, AIM

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mr Gavin Wood

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Abcam plc

b)

Legal Entity Identifier

N/A

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.2 pence each

 

 

 

GB00B6774699

b)

Nature of the transaction

Dividend Re-Investment

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

£8.44

3

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

3

£8.44

£25.32

f)

Date of the transaction

13 April 2017

g)

Place of the transaction

London Stock Exchange, AIM

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mrs Suzanne Smith

2

Reason for the notification

a)

Position/status

Chief Legal Officer and Company Secretary

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Abcam plc

b)

Legal Entity Identifier

N/A

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.2 pence each

 

 

 

GB00B6774699

b)

Nature of the transaction

Dividend Re-Investment

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

£8.44

7

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

7

£8.44

£59.08

f)

Date of the transaction

13 April 2017

g)

Place of the transaction

London Stock Exchange, AIM

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHXVLFFDZFLBBF
Date   Source Headline
2nd Mar 201812:43 pmRNSTotal Voting Rights
19th Feb 20188:44 amRNSBlock listing Interim Review
2nd Feb 20185:57 pmRNSHolding(s) in Company
1st Feb 201812:26 pmRNSTotal Voting Rights
22nd Jan 20187:00 amRNSAbcam Signs Exclusive License Agreement with Roche
18th Jan 201812:02 pmRNSHolding(s) in Company
8th Jan 201812:00 pmRNSAbcam present at J.P. Morgan Healthcare Conference
5th Jan 20187:00 amRNSHalf Year Trading Update
3rd Jan 20189:10 amRNSTotal Voting Rights
12th Dec 201710:37 amRNSDirector/PDMR Shareholding
1st Dec 20173:07 pmRNSTotal Voting Rights
15th Nov 20177:00 amRNSResult of AGM and Directorate Change
14th Nov 20177:00 amRNSAGM Statement
6th Nov 20174:48 pmRNSDirector/PDMR Shareholding
6th Nov 20174:42 pmRNSDirector/PDMR Shareholding
6th Nov 20174:40 pmRNSDirector/PDMR Shareholding
1st Nov 20174:46 pmRNSTotal Voting Rights
30th Oct 20179:55 amRNSDirector/PDMR Shareholding
17th Oct 20173:06 pmRNSHolding(s) in Company
11th Oct 20177:00 amRNSDirectorate Change
3rd Oct 201711:16 amRNSTotal Voting Rights
22nd Sep 20173:32 pmRNSAnnual Financial Report
22nd Sep 20177:00 amRNSDirector/PDMR Shareholding
18th Sep 20174:36 pmRNSDirector/PDMR Shareholding
11th Sep 20177:00 amRNSPreliminary Results
1st Sep 20179:41 amRNSTotal Voting Rights
25th Aug 201711:00 amRNSHolding(s) in Company
17th Aug 201710:00 amRNSHolding(s) in Company
9th Aug 20173:18 pmRNSBlock listing Interim Review
1st Aug 20179:45 amRNSTotal Voting Rights
27th Jul 20177:00 amRNSPre-Close Period Update
3rd Jul 20179:54 amRNSTotal Voting Rights
7th Jun 20174:23 pmRNSDirector/PDMR Shareholding
1st Jun 20172:41 pmRNSTotal Voting Rights
18th May 20173:17 pmRNSApplication for admission to trading
18th May 20177:00 amRNSFinal Performance-Based AxioMx Milestone Payment
3rd May 201711:25 amRNSDirector/PDMR Shareholding
2nd May 201710:27 amRNSTotal Voting Rights
18th Apr 20172:24 pmRNSDirector/PDMR Shareholding
10th Apr 20173:37 pmRNSDirector/PDMR Shareholding
3rd Apr 20171:53 pmRNSTotal Voting Rights
23rd Mar 20177:00 amRNSDirector/PDMR Shareholding
21st Mar 20177:00 amRNSDirector/PDMR Shareholding
6th Mar 20177:00 amRNSInterim Results
1st Mar 20174:05 pmRNSTotal Voting Rights
9th Feb 20178:52 amRNSBlock listing Interim Review
1st Feb 201712:09 pmRNSTotal Voting Rights
10th Jan 20177:00 amRNSHalf Year Trading Update
3rd Jan 20174:34 pmRNSTotal Voting Rights
15th Dec 201611:19 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.